Altimmune mourns passing of chief financial officer, richard eisenstadt

Gaithersburg, md., june 26, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that richard eisenstadt, the company's chief financial officer, passed away unexpectedly on monday, june 24, 2024.

ALT Ratings Summary

ALT Quant Ranking